Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)
NCT04443881
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
179
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Pnemonia
Interventions
DRUG:
Anakinra 149 MG/ML Prefilled Syringe [Kineret]
Sponsor
Fundacion Miguel Servet